| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5882913 | Clinical Lymphoma Myeloma and Leukemia | 2016 | 6 Pages |
Abstract
“Probable” PTC occurred in 1.7% of patients who received ATRA during induction and/or maintenance therapy. In agreement with previous reports, the incidence of PTC in APL patients receiving ATRA was higher in the pediatric population. Here, we discuss the method for diagnosing PTC in the setting of ATRA therapy and management strategies.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Anesthesiology and Pain Medicine
Authors
Catherine C. Coombs, Lisa M. DeAngelis, James H. Feusner, Jacob M. Rowe, Martin S. Tallman,